1-((1S,3S)-3-hydroxycyclopentyl)guanidine | 1395078-87-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-((1S,3S)-3-hydroxycyclopentyl)guanidine
• 英文别名: 2-[(1S,3S)-3-hydroxycyclopentyl]guanidine
• CAS: 1395078-87-1
• 化学式: C₆H₁₃N₃O
• 分子量: 143.189
• InChiKey: HUNAWQNQRQSVEE-WHFBIAKZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.1
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  84.6
• 氢给体数：
  3
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  tert-butyl 4-((dimethylamino)methylene)-3-oxopiperidine-1-carboxylate 、 1-((1S,3S)-3-hydroxycyclopentyl)guanidine 在 sodium ethanolate 作用下， 以 乙醇 为溶剂， 反应 18.0h， 生成 tert-butyl 2-((1S,3S)-3-hydroxycyclopentylamino)-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate
  参考文献：
  名称：

  Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2

  摘要：

  The discovery and optimization of a series of tetrahydropyridopyrimidine based extracellular signal-regulated kinase (Erks) inhibitors discovered via HTS and structure based drug design is reported. The compounds demonstrate potent and selective inhibition of Erk2 and knockdown of phospho-RSK levels in HepG2 cells and tumor xenografts. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2014.04.068
• 作为产物：
  描述：

  在 10 wt% Pd(OH)2 on carbon 、 氢气 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 16.0h， 生成 1-((1S,3S)-3-hydroxycyclopentyl)guanidine
  参考文献：
  名称：

  Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2

  摘要：

  The discovery and optimization of a series of tetrahydropyridopyrimidine based extracellular signal-regulated kinase (Erks) inhibitors discovered via HTS and structure based drug design is reported. The compounds demonstrate potent and selective inhibition of Erk2 and knockdown of phospho-RSK levels in HepG2 cells and tumor xenografts. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2014.04.068

文献信息

• [EN] BROAD-SPECTRUM CARBAPENEMS<br/>[FR] CARBAPÉNÈMES À LARGE SPECTRE
  申请人：VENATORX PHARMACEUTICALS INC

  公开号：WO2021101620A1

  公开（公告）日：2021-05-27

  The present disclosure provides broad-spectrum carbapenem derivatives and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such derivatives and/or compositions.

  本公开提供了广谱头孢菌素衍生物和制药组合物，用于治疗细菌感染，并提供了使用这些衍生物和/或组合物治疗此类感染的方法。
• SERINE/THREONINE KINASE INHIBITORS
  申请人：Blake James F.

  公开号：US20130338140A1

  公开（公告）日：2013-12-19

  Compounds having the formula I wherein Z, Z 1 Z 2 Z, R 3a , R 3b and R b and as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.

  具有I式的化合物，在此式中Z，Z1Z2Z，R3a，R3b和R3c的定义为ERK激酶的抑制剂。还披露了治疗过度增殖性疾病的组合物和方法。
• Serine/threonine kinase inhibitors
  申请人：Blake James F.

  公开号：US09133187B2

  公开（公告）日：2015-09-15

  Compounds having the formula I wherein Z, Z1 Z2 Z3, R3a, R3b and Rb and as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.

  具有I式的化合物，其中Z，Z1，Z2，Z3，R3a，R3b和Rb如本文所定义，是ERK激酶的抑制剂。还揭示了用于治疗过度增殖性疾病的组合物和方法。